BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/2/2024 9:08:46 AM | Browse: 174 | Download: 907
 |
Received |
|
2023-08-21 06:23 |
|
Peer-Review Started |
|
2023-08-21 06:25 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-11-28 01:00 |
|
Revised |
|
2023-11-30 16:46 |
|
Second Decision |
|
2023-12-15 02:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-12-15 06:50 |
|
Articles in Press |
|
2023-12-15 06:50 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-12-25 03:26 |
|
Publish the Manuscript Online |
|
2024-01-02 09:08 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhen Song, Qi Zhou, Jiang-Lei Zhang, Jun Ouyang and Zhi-Yu Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Suzhou Science and Technology Project |
SYS2019053 |
|
| Corresponding Author |
Zhi-Yu Zhang, PhD, Doctor, Doctor, Surgeon, Department of Urology, The First Affiliated Hospital of Soochow University, No. 188 Shizi Street, Gusu District, Suzhou 215000, Jiangsu Province, China. abner_666@126.com |
| Key Words |
Marker Ki-67; Prostate cancer; Biomarker; Diagnosis; Prognosis |
| Core Tip |
Marker Ki-67 (MKI67) has been established to correlate with the proliferation and metastasis of various malignant tumor cells, including those implicated in prostate cancer (PCa). Our objective is to validate the connection between MKI67 and the diagnosis as well as prognosis of PCa, by deploying two distinct patient cohorts from bioinformatics and clinical data. Within the bioinformatics data cohort, comprising 496 PCa tissue samples juxtaposed with 152 normal controls, we ascertained that MKI67 possesses a strong diagnostic ability for PCa along with a moderate prognostic prediction potential. Similarly, through our retrospective analysis of clinical data from 271 PCa patients, we confirmed the potent diagnostic capacity of MKI67 for PCa and its capability to predict prognosis to a certain extent. |
| Publish Date |
2024-01-02 09:08 |
| Citation |
Song Z, Zhou Q, Zhang JL, Ouyang J, Zhang ZY. Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts. World J Clin Cases 2024; 12(1): 32-41 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i1/32.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i1.32 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
